JDRF Blog

Latest in Research

  • JDRF Research Strategy: Cures and Improving Lives

    May 31, 2019

    They shared new developments and applauded the speed of scientific advancements. At this year’s Strategic Research Session, the tone was dynamic as...

  • The 20th Anniversary of the Edmonton Protocol

    March 11, 2019

    This day, 20 years ago, a person with type 1 diabetes (T1D) was cured. Well, pseudo-cured. On March 11, 1999, the Edmonton...

  • A Team in Boston Trying to Prevent Type 1 Diabetes

    October 29, 2019

    JDRF is funding work on multiple ways to delay or prevent the onset of type 1 diabetes (T1D). This team thinks fat...

  • JDRF Brings Together Leading Experts at Islet Targeting Workshop 

    October 23, 2019

    JDRF is committed is to curing type 1 diabetes (T1D) through beta cell therapies, which is a complicated problem with myriad potential...

  • Can Two Viral Drugs Halt Type 1 Diabetes?

    October 17, 2019

    Scientists in Norway are seeking participants for a clinical trial to see if a course of anti-viral treatment may stop beta cell...

  • Get To Know the Key People Behind Beta Cell Replacement Therapy in Boston

    October 15, 2019

    Join us for an inside look at the collaborations and skills that researchers in Boston are using to tackle the complex task...

  • Join Us "Inside the Lab at Boston"

    October 8, 2019

    The work of type 1 diabetes (T1D) researchers is so compelling and full of hope. But it also is a bit shrouded...

  • FDA Approves Xeris Pharmaceuticals’ Glucagon to Treat Severe Hypoglycemia

    September 11, 2019

    “The approval of the GVOKE HypoPenTM is an important step forward for people with diabetes. Severe hypoglycemia is a terrifying and dangerous...